- Home
- ATNI vs TRDA Comparison
ATNI vs TRDA Comparison
Compare ATNI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- TRDA
- Stock Information
- Founded
- ATNI 1987
- TRDA 2016
- Country
- ATNI United States
- TRDA United States
- Employees
- ATNI N/A
- TRDA N/A
- Industry
- ATNI Telecommunications Equipment
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- ATNI Telecommunications
- TRDA Health Care
- Exchange
- ATNI Nasdaq
- TRDA Nasdaq
- Market Cap
- ATNI 254.3M
- TRDA 233.5M
- IPO Year
- ATNI 1991
- TRDA 2021
- Fundamental
- Price
- ATNI $15.57
- TRDA $5.06
- Analyst Decision
- ATNI Strong Buy
- TRDA Strong Buy
- Analyst Count
- ATNI 1
- TRDA 3
- Target Price
- ATNI $30.00
- TRDA $25.67
- AVG Volume (30 Days)
- ATNI 32.1K
- TRDA 219.8K
- Earning Date
- ATNI 10-28-2025
- TRDA 11-04-2025
- Dividend Yield
- ATNI 6.97%
- TRDA N/A
- EPS Growth
- ATNI N/A
- TRDA N/A
- EPS
- ATNI N/A
- TRDA N/A
- Revenue
- ATNI $719,593,000.00
- TRDA $79,476,000.00
- Revenue This Year
- ATNI $1.60
- TRDA N/A
- Revenue Next Year
- ATNI $1.38
- TRDA N/A
- P/E Ratio
- ATNI N/A
- TRDA N/A
- Revenue Growth
- ATNI N/A
- TRDA N/A
- 52 Week Low
- ATNI $13.76
- TRDA $4.93
- 52 Week High
- ATNI $33.72
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- ATNI 45.45
- TRDA 38.29
- Support Level
- ATNI $15.22
- TRDA $5.08
- Resistance Level
- ATNI $17.01
- TRDA $5.49
- Average True Range (ATR)
- ATNI 0.98
- TRDA 0.24
- MACD
- ATNI -0.01
- TRDA 0.00
- Stochastic Oscillator
- ATNI 22.44
- TRDA 4.11
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.